SEC Form 4 · accession 0001144204-18-012627
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua Silverman
Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | J | 153,333 | $0.00 | A | 153,333 | I | By JNS Holdings Group LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Warrants | $1.20 | Feb 28, 2018 | J | 41,667 | A | Jan 16, 2015 | Jan 16, 2020 | Common Stock | 41,667 | 41,667 | I |
| Series C Warrants | $6.00 | Feb 28, 2018 | J | 44,000 | A | Jan 16, 2015 | Jan 16, 2020 | Common Stock | 44,000 | 44,000 | I |
| Series D Warrants | $9.00 | Feb 28, 2018 | J | 41,667 | A | Jan 16, 2015 | Jan 16, 2020 | Common Stock | 41,667 | 41,667 | I |
| Series E Warrants | $4.50 | Feb 28, 2018 | J | 10,574 | A | Jan 16, 2015 | Oct 8, 2020 | Common Stock | 10,574 | 10,574 | I |
| Series E-1 Warrants | $15.00 | Feb 28, 2018 | J | 31,093 | A | Mar 9, 2015 | Oct 8, 2020 | Common Stock | 31,093 | 31,093 | I |
| Series F Warrants | $7.20 | Feb 28, 2018 | J | 49,167 | A | Jan 16, 2015 | Aug 11, 2021 | Common Stock | 49,167 | 49,167 | I |
Explanation of responses
- F1Securities received from pro rata distribution in connection with the dissolution of American Capital Management LLC, of which the reporting person was a non-managing member.